_
Rehovot Scientist served a keynote speaker at the US Science Congress
Prof. Michal Schwartz of the Weizmann Institute of Science, Proneuron's scientific founder is chosen as the keynote speaker at the First Joint Conference of the American Spinal Injury Association and The International Medical Society of Paraplegia
Rehovot (6 May 2002) Proneuron Biotechnologies, Inc. announced today that its scientific founder, Prof. Michal Schwartz, of the Neuroimmunology department at the Weizmann Institute of Science, Israel, was chosen by the American Spinal Injury Association (ASIA) to give the G. Heiner Sell Lecture at a plenary session of the 2002 Joint ASIA-IMSOP Annual Conference, held in Vancouver. The invitation to give this keynote presentation in front of the leading rehabilitation specialists was made in recognition of groundbreaking research on immune-modulation to promote spinal cord recovery following acute injuries. Prof. Schwartz and her team at the Weizmann Institute made the discovery that activated macrophages induce functional recovery in the damaged spinal cord of laboratory rats. Proneuron Biotechnologies, the exclusive licensee of the technology, subsequently developed the initial discovery into a human clinical program.
See http://www.proneuron.com for more information.
Contact: Nir Nimrodi, CEO, Tel. +972-8-9409550, Email: nir.nimrodi@proneuron.com
The Weizmann Institute of Science, in Rehovot, Israel, is one of the world's foremost centers of scientific research and graduate study. Its 2,500 scientists, students, technicians, and engineers pursue basic research in the quest for knowledge and the enhancement of humanity. New ways of fighting disease and hunger, protecting the environment, and harnessing alternative sources of energy are high
priorities at the Weizmann Institute of Science.
Contact: Yivsam Azgad, Spokesman, Tel. +972-8-934-3856, Email: Yivsam.Azgad@weizmann.ac.il , And News@Weizmann.ac.il , For more information please see http://Wis-Wander.weizmann.ac.il
Rehovot (6 May 2002) Proneuron Biotechnologies, Inc. announced today that its scientific founder, Prof. Michal Schwartz, of the Neuroimmunology department at the Weizmann Institute of Science, Israel, was chosen by the American Spinal Injury Association (ASIA) to give the G. Heiner Sell Lecture at a plenary session of the 2002 Joint ASIA-IMSOP Annual Conference, held in Vancouver. The invitation to give this keynote presentation in front of the leading rehabilitation specialists was made in recognition of groundbreaking research on immune-modulation to promote spinal cord recovery following acute injuries. Prof. Schwartz and her team at the Weizmann Institute made the discovery that activated macrophages induce functional recovery in the damaged spinal cord of laboratory rats. Proneuron Biotechnologies, the exclusive licensee of the technology, subsequently developed the initial discovery into a human clinical program.
See http://www.proneuron.com for more information.
Contact: Nir Nimrodi, CEO, Tel. +972-8-9409550, Email: nir.nimrodi@proneuron.com
The Weizmann Institute of Science, in Rehovot, Israel, is one of the world's foremost centers of scientific research and graduate study. Its 2,500 scientists, students, technicians, and engineers pursue basic research in the quest for knowledge and the enhancement of humanity. New ways of fighting disease and hunger, protecting the environment, and harnessing alternative sources of energy are high
priorities at the Weizmann Institute of Science.
Contact: Yivsam Azgad, Spokesman, Tel. +972-8-934-3856, Email: Yivsam.Azgad@weizmann.ac.il , And News@Weizmann.ac.il , For more information please see http://Wis-Wander.weizmann.ac.il
0 Comments:
Post a Comment
<< Home